Pan, G.; Roy, B.; Giri, S.; Lanfear, D.E.; Thandavarayan, R.A.; Guha, A.; Ortiz, P.A.; Palaniyandi, S.S.
Aldehyde Dehydrogenase 2 Activator Augments the Beneficial Effects of Empagliflozin in Mice with Diabetes-Associated HFpEF. Int. J. Mol. Sci. 2022, 23, 10439.
https://doi.org/10.3390/ijms231810439
AMA Style
Pan G, Roy B, Giri S, Lanfear DE, Thandavarayan RA, Guha A, Ortiz PA, Palaniyandi SS.
Aldehyde Dehydrogenase 2 Activator Augments the Beneficial Effects of Empagliflozin in Mice with Diabetes-Associated HFpEF. International Journal of Molecular Sciences. 2022; 23(18):10439.
https://doi.org/10.3390/ijms231810439
Chicago/Turabian Style
Pan, Guodong, Bipradas Roy, Shailendra Giri, David E. Lanfear, Rajarajan A. Thandavarayan, Ashrith Guha, Pablo A. Ortiz, and Suresh Selvaraj Palaniyandi.
2022. "Aldehyde Dehydrogenase 2 Activator Augments the Beneficial Effects of Empagliflozin in Mice with Diabetes-Associated HFpEF" International Journal of Molecular Sciences 23, no. 18: 10439.
https://doi.org/10.3390/ijms231810439
APA Style
Pan, G., Roy, B., Giri, S., Lanfear, D. E., Thandavarayan, R. A., Guha, A., Ortiz, P. A., & Palaniyandi, S. S.
(2022). Aldehyde Dehydrogenase 2 Activator Augments the Beneficial Effects of Empagliflozin in Mice with Diabetes-Associated HFpEF. International Journal of Molecular Sciences, 23(18), 10439.
https://doi.org/10.3390/ijms231810439
